Since c-FLIPL and Mcl-1 were known as substrates of caspases [34,35], it could be possible that TRAIL-induced potent activation of caspases in metastatic cancer cells led to accelerated down-regulation of c-FLIPL and Mcl-1. Here, MCL1 is linked to metastatic malignant neoplasm.